Showing results (1911-1920 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|February 26, 2026
Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemiaYewei Wang, Doudou Tang, Zhao Cheng, et al.
Haematologica|March 5, 2026
Genetic and clinical characteristics of 54 pediatric lymphoma patients with variant mutation sites of UNC13DYanlong Duan, Huixia Gao, Ling Jin, et al.
Haematologica|March 5, 2026
GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa studyRichard F Schlenk, Claire N Harrison, Francesca Palandri, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Haematologica|April 2, 2026
Preemptive hematopoietic stem cell transplantation in RUNX1 familial platelet disorder: a shared decision-making frameworkTimothy S Olson, Katrin Ericson, Joseph H Antin, et al.
Haematologica|April 2, 2026
Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemiaGuillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Haematologica|April 2, 2026
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case reportCarmen de Ramon Ortiz, Hana Abouzeid, Chiara De Bernardi, et al.
Haematologica|April 2, 2026
Phenotypic evolution of circulating plasma cells from early precursor stages to multiple myelomaMartin Pietzsch, Sina Alexandra Beer, Lucca Marco Kimmich, et al.
Haematologica|February 26, 2026
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label studyGeoffrey Z L Kuppens, Maria Armila D Ruiz, Myrthe J Van Dijk, et al.
Haematologica|April 2, 2026
Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significanceDespina Fotiou, Darko Antic, Aurelien Delluc, et al.
Pageof 816